Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 49 to 58 of 58 entries
Sorted by: Best Match Show Resources per page
Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantation.

Open heart

Massey RJ, Diep PP, Burman MM, Kvaslerud AB, Brinch L, Aakhus S, Gullestad L, Ruud E, Beitnes JO.
PMID: 34933961
Open Heart. 2021 Dec;8(2). doi: 10.1136/openhrt-2021-001768.

AIMS: Survivors of allogeneic haematopoietic stem-cell transplantation (allo-HSCT) are at higher risk of cardiovascular disease. We aimed to describe right ventricular (RV) systolic function and risk factors for RV dysfunction in long-term survivors of allo-HSCT performed in their youth.METHODS...

Cite
Massey RJ, Diep PP, Burman MM, et al. Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantation. Open Heart. 2021;8(2)doi: 10.1136/openhrt-2021-001768.
Massey, R. J., Diep, P. P., Burman, M. M., Kvaslerud, A. B., Brinch, L., Aakhus, S., Gullestad, L., Ruud, E., & Beitnes, J. O. (2021). Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantation. Open heart, 8(2), . https://doi.org/10.1136/openhrt-2021-001768
Massey, Richard John, et al. "Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantation." Open heart vol. 8,2 (2021). doi: https://doi.org/10.1136/openhrt-2021-001768
Massey RJ, Diep PP, Burman MM, Kvaslerud AB, Brinch L, Aakhus S, Gullestad L, Ruud E, Beitnes JO. Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantation. Open Heart. 2021 Dec;8(2). doi: 10.1136/openhrt-2021-001768. PMID: 34933961.
Copy Download .nbib Format: NLM
Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation.

European heart journal

Ahn JM, Zimmermann FM, Arora S, Solberg OG, Angerås O, Rolid K, Rafique M, Aaberge L, Karason K, Okada K, Luikart H, Khush KK, Honda Y, Pijls NHJ, Lee SE, Kim JJ, Park SJ, Gullestad L, Fearon WF.
PMID: 34665224
Eur Heart J. 2021 Oct 19; doi: 10.1093/eurheartj/ehab568. Epub 2021 Oct 19.

AIMS: We evaluated the long-term prognostic value of invasively assessing coronary physiology after heart transplantation in a large multicentre registry.METHODS AND RESULTS: Comprehensive intracoronary physiology assessment measuring fractional flow reserve (FFR), the index of microcirculatory resistance (IMR), and coronary...

Cite
Ahn JM, Zimmermann FM, Arora S, et al. Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation. Eur Heart J. 2021;doi: 10.1093/eurheartj/ehab568.
Ahn, J. M., Zimmermann, F. M., Arora, S., Solberg, O. G., Angerås, O., Rolid, K., Rafique, M., Aaberge, L., Karason, K., Okada, K., Luikart, H., Khush, K. K., Honda, Y., Pijls, N. H. J., Lee, S. E., Kim, J. J., Park, S. J., Gullestad, L., & Fearon, W. F. (2021). Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation. European heart journal, . https://doi.org/10.1093/eurheartj/ehab568
Ahn, Jung-Min, et al. "Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation." European heart journal vol. (2021). doi: https://doi.org/10.1093/eurheartj/ehab568
Ahn JM, Zimmermann FM, Arora S, Solberg OG, Angerås O, Rolid K, Rafique M, Aaberge L, Karason K, Okada K, Luikart H, Khush KK, Honda Y, Pijls NHJ, Lee SE, Kim JJ, Park SJ, Gullestad L, Fearon WF. Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation. Eur Heart J. 2021 Oct 19; doi: 10.1093/eurheartj/ehab568. Epub 2021 Oct 19. PMID: 34665224.
Copy Download .nbib Format: NLM
Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation.

European heart journal

Ahn JM, Zimmermann FM, Arora S, Solberg OG, Angerås O, Rolid K, Rafique M, Aaberge L, Karason K, Okada K, Luikart H, Khush KK, Honda Y, Pijls NHJ, Lee SE, Kim JJ, Park SJ, Gullestad L, Fearon WF.
PMID: 34665224
Eur Heart J. 2021 Dec 21;42(48):4918-4929. doi: 10.1093/eurheartj/ehab568.

AIMS: We evaluated the long-term prognostic value of invasively assessing coronary physiology after heart transplantation in a large multicentre registry.METHODS AND RESULTS: Comprehensive intracoronary physiology assessment measuring fractional flow reserve (FFR), the index of microcirculatory resistance (IMR), and coronary...

Cite
Ahn JM, Zimmermann FM, Arora S, et al. Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation. Eur Heart J. 2021;42(48):4918-4929doi: 10.1093/eurheartj/ehab568.
Ahn, J. M., Zimmermann, F. M., Arora, S., Solberg, O. G., Angerås, O., Rolid, K., Rafique, M., Aaberge, L., Karason, K., Okada, K., Luikart, H., Khush, K. K., Honda, Y., Pijls, N. H. J., Lee, S. E., Kim, J. J., Park, S. J., Gullestad, L., & Fearon, W. F. (2021). Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation. European heart journal, 42(48), 4918-4929. https://doi.org/10.1093/eurheartj/ehab568
Ahn, Jung-Min, et al. "Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation." European heart journal vol. 42,48 (2021): 4918-4929. doi: https://doi.org/10.1093/eurheartj/ehab568
Ahn JM, Zimmermann FM, Arora S, Solberg OG, Angerås O, Rolid K, Rafique M, Aaberge L, Karason K, Okada K, Luikart H, Khush KK, Honda Y, Pijls NHJ, Lee SE, Kim JJ, Park SJ, Gullestad L, Fearon WF. Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation. Eur Heart J. 2021 Dec 21;42(48):4918-4929. doi: 10.1093/eurheartj/ehab568. PMID: 34665224; PMCID: PMC8691805.
Copy Download .nbib Format: NLM
Growth differentiation factor 15 predicts poor prognosis in patients with heart failure and reduced ejection fraction and anemia: results from RED-HF.

Clinical research in cardiology : official journal of the German Cardiac Society

Ueland T, Gullestad L, Kou L, Young JB, Pfeffer MA, van Veldhuisen DJ, Swedberg K, Mcmurray JJV, Desai AS, Anand IS, Aukrust P.
PMID: 34611778
Clin Res Cardiol. 2021 Oct 05; doi: 10.1007/s00392-021-01944-6. Epub 2021 Oct 05.

AIMS: We aimed to assess the value of GDF-15, a stress-responsive cytokine, in predicting clinical outcomes in patients with heart failure (HF) with reduced ejection fraction (HFrEF) and anemia METHODS AND RESULTS: Serum GDF-15 was assessed in 1582 HFrEF...

Cite
Ueland T, Gullestad L, Kou L, et al. Growth differentiation factor 15 predicts poor prognosis in patients with heart failure and reduced ejection fraction and anemia: results from RED-HF. Clin Res Cardiol. 2021;doi: 10.1007/s00392-021-01944-6.
Ueland, T., Gullestad, L., Kou, L., Young, J. B., Pfeffer, M. A., van Veldhuisen, D. J., Swedberg, K., Mcmurray, J. J. V., Desai, A. S., Anand, I. S., & Aukrust, P. (2021). Growth differentiation factor 15 predicts poor prognosis in patients with heart failure and reduced ejection fraction and anemia: results from RED-HF. Clinical research in cardiology : official journal of the German Cardiac Society, . https://doi.org/10.1007/s00392-021-01944-6
Ueland, Thor, et al. "Growth differentiation factor 15 predicts poor prognosis in patients with heart failure and reduced ejection fraction and anemia: results from RED-HF." Clinical research in cardiology : official journal of the German Cardiac Society vol. (2021). doi: https://doi.org/10.1007/s00392-021-01944-6
Ueland T, Gullestad L, Kou L, Young JB, Pfeffer MA, van Veldhuisen DJ, Swedberg K, Mcmurray JJV, Desai AS, Anand IS, Aukrust P. Growth differentiation factor 15 predicts poor prognosis in patients with heart failure and reduced ejection fraction and anemia: results from RED-HF. Clin Res Cardiol. 2021 Oct 05; doi: 10.1007/s00392-021-01944-6. Epub 2021 Oct 05. PMID: 34611778.
Copy Download .nbib Format: NLM
Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantation.

Open heart

Massey RJ, Diep PP, Burman MM, Kvaslerud AB, Brinch L, Aakhus S, Gullestad L, Ruud E, Beitnes JO.
PMID: 34933961
Open Heart. 2021 Dec;8(2). doi: 10.1136/openhrt-2021-001768.

AIMS: Survivors of allogeneic haematopoietic stem-cell transplantation (allo-HSCT) are at higher risk of cardiovascular disease. We aimed to describe right ventricular (RV) systolic function and risk factors for RV dysfunction in long-term survivors of allo-HSCT performed in their youth.METHODS...

Cite
Massey RJ, Diep PP, Burman MM, et al. Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantation. Open Heart. 2021;8(2)doi: 10.1136/openhrt-2021-001768.
Massey, R. J., Diep, P. P., Burman, M. M., Kvaslerud, A. B., Brinch, L., Aakhus, S., Gullestad, L., Ruud, E., & Beitnes, J. O. (2021). Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantation. Open heart, 8(2), . https://doi.org/10.1136/openhrt-2021-001768
Massey, Richard John, et al. "Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantation." Open heart vol. 8,2 (2021). doi: https://doi.org/10.1136/openhrt-2021-001768
Massey RJ, Diep PP, Burman MM, Kvaslerud AB, Brinch L, Aakhus S, Gullestad L, Ruud E, Beitnes JO. Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantation. Open Heart. 2021 Dec;8(2). doi: 10.1136/openhrt-2021-001768. PMID: 34933961.
Copy Download .nbib Format: NLM
A randomized clinical study using optical coherence tomography to evaluate the short-term effects of high-intensity interval training on cardiac allograft vasculopathy: a HITTS substudy.

Clinical transplantation

Rafique M, Solberg OG, Gullestad L, Bendz B, Holm NR, Neghabat O, Dijkstra J, Nytrøen K, Rolid K, Lunde K.
PMID: 34747048
Clin Transplant. 2021 Nov 07;e14488. doi: 10.1111/ctr.14488. Epub 2021 Nov 07.

Cardiac allograft vasculopathy (CAV) remains a leading cause of long-term mortality after heart transplantation. Both preventive measures and treatment options are limited. This study aimed to evaluate the short-term effects of high-intensity interval training (HIT) on CAV in de...

Cite
Rafique M, Solberg OG, Gullestad L, et al. A randomized clinical study using optical coherence tomography to evaluate the short-term effects of high-intensity interval training on cardiac allograft vasculopathy: a HITTS substudy. Clin Transplant. 2021;e14488doi: 10.1111/ctr.14488.
Rafique, M., Solberg, O. G., Gullestad, L., Bendz, B., Holm, N. R., Neghabat, O., Dijkstra, J., Nytrøen, K., Rolid, K., & Lunde, K. (2021). A randomized clinical study using optical coherence tomography to evaluate the short-term effects of high-intensity interval training on cardiac allograft vasculopathy: a HITTS substudy. Clinical transplantation, e14488. https://doi.org/10.1111/ctr.14488
Rafique, Muzammil, et al. "A randomized clinical study using optical coherence tomography to evaluate the short-term effects of high-intensity interval training on cardiac allograft vasculopathy: a HITTS substudy." Clinical transplantation vol. (2021): e14488. doi: https://doi.org/10.1111/ctr.14488
Rafique M, Solberg OG, Gullestad L, Bendz B, Holm NR, Neghabat O, Dijkstra J, Nytrøen K, Rolid K, Lunde K. A randomized clinical study using optical coherence tomography to evaluate the short-term effects of high-intensity interval training on cardiac allograft vasculopathy: a HITTS substudy. Clin Transplant. 2021 Nov 07;e14488. doi: 10.1111/ctr.14488. Epub 2021 Nov 07. PMID: 34747048.
Copy Download .nbib Format: NLM
Left Ventricular Systolic Function in Long-Term Survivors of Allogeneic Hematopoietic Stem Cell Transplantation.

JACC. CardioOncology

Massey RJ, Diep PP, Ruud E, Burman MM, Kvaslerud AB, Brinch L, Aakhus S, Gullestad LL, Beitnes JO.
PMID: 34396253
JACC CardioOncol. 2020 Sep 15;2(3):460-471. doi: 10.1016/j.jaccao.2020.06.011. eCollection 2020 Sep.

BACKGROUND: Allogeneic hematopoietic stem cell transplantation (allo-HSCT), a potentially curative therapy for malignant and nonmalignant diseases, is being increasingly used in younger patients. Although allo-HSCT survivors have an established increased risk of cardiovascular disease, there is limited knowledge of...

Cite
Massey RJ, Diep PP, Ruud E, et al. Left Ventricular Systolic Function in Long-Term Survivors of Allogeneic Hematopoietic Stem Cell Transplantation. JACC CardioOncol. 2020;2(3):460-471doi: 10.1016/j.jaccao.2020.06.011.
Massey, R. J., Diep, P. P., Ruud, E., Burman, M. M., Kvaslerud, A. B., Brinch, L., Aakhus, S., Gullestad, L. L., & Beitnes, J. O. (2020). Left Ventricular Systolic Function in Long-Term Survivors of Allogeneic Hematopoietic Stem Cell Transplantation. JACC. CardioOncology, 2(3), 460-471. https://doi.org/10.1016/j.jaccao.2020.06.011
Massey, Richard J, et al. "Left Ventricular Systolic Function in Long-Term Survivors of Allogeneic Hematopoietic Stem Cell Transplantation." JACC. CardioOncology vol. 2,3 (2020): 460-471. doi: https://doi.org/10.1016/j.jaccao.2020.06.011
Massey RJ, Diep PP, Ruud E, Burman MM, Kvaslerud AB, Brinch L, Aakhus S, Gullestad LL, Beitnes JO. Left Ventricular Systolic Function in Long-Term Survivors of Allogeneic Hematopoietic Stem Cell Transplantation. JACC CardioOncol. 2020 Sep 15;2(3):460-471. doi: 10.1016/j.jaccao.2020.06.011. eCollection 2020 Sep. PMID: 34396253; PMCID: PMC8352258.
Copy Download .nbib Format: NLM
The Alternative Complement Pathway Is Activated Without a Corresponding Terminal Pathway Activation in Patients With Heart Failure.

Frontiers in immunology

Holt MF, Michelsen AE, Shahini N, Bjørkelund E, Bendz CH, Massey RJ, Schjalm C, Halvorsen B, Broch K, Ueland T, Gullestad L, Nilsson PH, Aukrust P, Mollnes TE, Louwe MC.
PMID: 35003128
Front Immunol. 2021 Dec 24;12:800978. doi: 10.3389/fimmu.2021.800978. eCollection 2021.

OBJECTIVE: Dysregulation of the complement system has been described in patients with heart failure (HF). However, data on the alternative pathway are scarce and it is unknown if levels of factor B (FB) and the C3 convertase C3bBbP are...

Cite
Holt MF, Michelsen AE, Shahini N, et al. The Alternative Complement Pathway Is Activated Without a Corresponding Terminal Pathway Activation in Patients With Heart Failure. Front Immunol. 2021;12:800978doi: 10.3389/fimmu.2021.800978.
Holt, M. F., Michelsen, A. E., Shahini, N., Bjørkelund, E., Bendz, C. H., Massey, R. J., Schjalm, C., Halvorsen, B., Broch, K., Ueland, T., Gullestad, L., Nilsson, P. H., Aukrust, P., Mollnes, T. E., & Louwe, M. C. (2021). The Alternative Complement Pathway Is Activated Without a Corresponding Terminal Pathway Activation in Patients With Heart Failure. Frontiers in immunology, 12800978. https://doi.org/10.3389/fimmu.2021.800978
Holt, Margrethe Flesvig, et al. "The Alternative Complement Pathway Is Activated Without a Corresponding Terminal Pathway Activation in Patients With Heart Failure." Frontiers in immunology vol. 12 (2021): 800978. doi: https://doi.org/10.3389/fimmu.2021.800978
Holt MF, Michelsen AE, Shahini N, Bjørkelund E, Bendz CH, Massey RJ, Schjalm C, Halvorsen B, Broch K, Ueland T, Gullestad L, Nilsson PH, Aukrust P, Mollnes TE, Louwe MC. The Alternative Complement Pathway Is Activated Without a Corresponding Terminal Pathway Activation in Patients With Heart Failure. Front Immunol. 2021 Dec 24;12:800978. doi: 10.3389/fimmu.2021.800978. eCollection 2021. PMID: 35003128; PMCID: PMC8738166.
Copy Download .nbib Format: NLM
Challenges in coronary heart disease prevention - experiences from a long-term follow-up study in Norway.

Scandinavian cardiovascular journal : SCJ

Sverre E, Peersen K, Perk J, Husebye E, Gullestad L, Dammen T, Otterstad JE, Munkhaugen J.
PMID: 33274648
Scand Cardiovasc J. 2021 Apr;55(2):73-81. doi: 10.1080/14017431.2020.1852308. Epub 2020 Dec 04.

No abstract available.

Cite
Sverre E, Peersen K, Perk J, et al. Challenges in coronary heart disease prevention - experiences from a long-term follow-up study in Norway. Scand Cardiovasc J. 2020;55(2):73-81doi: 10.1080/14017431.2020.1852308.
Sverre, E., Peersen, K., Perk, J., Husebye, E., Gullestad, L., Dammen, T., Otterstad, J. E., & Munkhaugen, J. (2021). Challenges in coronary heart disease prevention - experiences from a long-term follow-up study in Norway. Scandinavian cardiovascular journal : SCJ, 55(2), 73-81. https://doi.org/10.1080/14017431.2020.1852308
Sverre, E, et al. "Challenges in coronary heart disease prevention - experiences from a long-term follow-up study in Norway." Scandinavian cardiovascular journal : SCJ vol. 55,2 (2021): 73-81. doi: https://doi.org/10.1080/14017431.2020.1852308
Sverre E, Peersen K, Perk J, Husebye E, Gullestad L, Dammen T, Otterstad JE, Munkhaugen J. Challenges in coronary heart disease prevention - experiences from a long-term follow-up study in Norway. Scand Cardiovasc J. 2021 Apr;55(2):73-81. doi: 10.1080/14017431.2020.1852308. Epub 2020 Dec 04. PMID: 33274648.
Copy Download .nbib Format: NLM
Strong evidence for parasympathetic sinoatrial reinnervation after heart transplantation.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Christensen AH, Nygaard S, Rolid K, Nytrøen K, Gullestad L, Fiane A, Thaulow E, Døhlen G, Saul JP, Wyller VBB.
PMID: 34924265
J Heart Lung Transplant. 2021 Nov 15; doi: 10.1016/j.healun.2021.11.005. Epub 2021 Nov 15.

BACKGROUND: Heart transplantation (HTx) surgically denervates the heart. We examined indices of sinoatrial reinnervation, with emphasis on (1) the occurrence and timing of parasympathetic reinnervation, and (2) the consequences of reinnervation for heart rate (HR) responsiveness and arterial baroreceptor...

Cite
Christensen AH, Nygaard S, Rolid K, et al. Strong evidence for parasympathetic sinoatrial reinnervation after heart transplantation. J Heart Lung Transplant. 2021;doi: 10.1016/j.healun.2021.11.005.
Christensen, A. H., Nygaard, S., Rolid, K., Nytrøen, K., Gullestad, L., Fiane, A., Thaulow, E., Døhlen, G., Saul, J. P., & Wyller, V. B. B. (2021). Strong evidence for parasympathetic sinoatrial reinnervation after heart transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, . https://doi.org/10.1016/j.healun.2021.11.005
Christensen, Anders H, et al. "Strong evidence for parasympathetic sinoatrial reinnervation after heart transplantation." The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation vol. (2021). doi: https://doi.org/10.1016/j.healun.2021.11.005
Christensen AH, Nygaard S, Rolid K, Nytrøen K, Gullestad L, Fiane A, Thaulow E, Døhlen G, Saul JP, Wyller VBB. Strong evidence for parasympathetic sinoatrial reinnervation after heart transplantation. J Heart Lung Transplant. 2021 Nov 15; doi: 10.1016/j.healun.2021.11.005. Epub 2021 Nov 15. PMID: 34924265.
Copy Download .nbib Format: NLM
Showing 49 to 58 of 58 entries